0001181431-11-018577.txt : 20110317
0001181431-11-018577.hdr.sgml : 20110317
20110317081504
ACCESSION NUMBER: 0001181431-11-018577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110315
FILED AS OF DATE: 20110317
DATE AS OF CHANGE: 20110317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reisenauer Mark L
CENTRAL INDEX KEY: 0001413481
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50440
FILM NUMBER: 11693658
MAIL ADDRESS:
STREET 1: 6707 DEMOCRACY BOULEVARD
STREET 2: SUITE 505
CITY: BETHESDA
STATE: MD
ZIP: 20817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MICROMET, INC.
CENTRAL INDEX KEY: 0001131907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522243564
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6707 DEMOCRACY BOULEVARD
STREET 2: SUITE 505
CITY: BETHESDA
STATE: MD
ZIP: 20817
BUSINESS PHONE: 240-752-1420
MAIL ADDRESS:
STREET 1: 6707 DEMOCRACY BOULEVARD
STREET 2: SUITE 505
CITY: BETHESDA
STATE: MD
ZIP: 20817
FORMER COMPANY:
FORMER CONFORMED NAME: CANCERVAX CORP
DATE OF NAME CHANGE: 20010108
4
1
rrd305679.xml
REISENAUER FORM 4
X0303
4
2011-03-15
0
0001131907
MICROMET, INC.
MITI
0001413481
Reisenauer Mark L
6707 DEMOCRACY BLVD
BETHESDA
MD
20817
0
1
0
0
SVP, Chief Commercial Officer
Common Stock
2011-03-15
4
M
0
111100
1.98
D
111100
D
Common Stock
2011-03-15
4
S
0
111100
5.1085
D
0
D
Stock Option (right to buy)
1.98
2011-03-15
4
M
0
90909
0
D
2011-03-01
2017-10-01
Common Stock
90909
35354
D
Stock Option (right to buy)
1.98
2011-03-15
4
M
0
20191
0
D
2010-12-01
2017-10-01
Common Stock
20191
28547
D
Price reflected is the weighed-average sale price for shares sold. The range of sale prices for the transactions reported was $5.10 to $5.1274 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the shares underlying this option vested on October 1, 2008, with the remainder vesting in equal monthly installments through October 1, 2011.
/s/ Janet Hanson, attorney-in-fact
2011-03-17